Marek Widera

5.8k total citations · 2 hit papers
71 papers, 2.2k citations indexed

About

Marek Widera is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Marek Widera has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 23 papers in Molecular Biology and 20 papers in Virology. Recurrent topics in Marek Widera's work include SARS-CoV-2 and COVID-19 Research (27 papers), HIV Research and Treatment (19 papers) and COVID-19 Clinical Research Studies (15 papers). Marek Widera is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (27 papers), HIV Research and Treatment (19 papers) and COVID-19 Clinical Research Studies (15 papers). Marek Widera collaborates with scholars based in Germany, United States and United Kingdom. Marek Widera's co-authors include Sandra Ciesek, Denisa Bojková, Jindřich Činátl, Benjamin Koch, Kevin Klann, Christian Münch, David Krause, Sandra Westhaus, Heiner Schaal and Tuna Toptan and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Marek Widera

71 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

2020 642 citations Denisa Bojková, Kevin Klann et al. Nature profile →
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

2022 109 citations Alexander Wilhelm, Marek Widera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marek Widera Germany	22	1.4k	703	338	332	266	71	2.2k
Hiroshi Katoh Japan	15	1.3k 0.9×	440 0.6×	212 0.6×	159 0.5×	332 1.2×	38	1.9k
Susanne Pfefferle Germany	24	2.4k 1.7×	492 0.7×	267 0.8×	117 0.4×	392 1.5×	63	3.2k
Reed F. Johnson United States	29	2.1k 1.5×	628 0.9×	319 0.9×	107 0.3×	778 2.9×	85	3.2k
Linfang Cheng China	20	928 0.7×	489 0.7×	310 0.9×	108 0.3×	636 2.4×	77	1.9k
Yong Feng China	20	1.5k 1.0×	703 1.0×	226 0.7×	119 0.4×	249 0.9×	63	2.5k
Fumihiro Kato Japan	16	1.4k 1.0×	322 0.5×	147 0.4×	147 0.4×	242 0.9×	49	2.0k
Zhuoming Liu United States	18	1.7k 1.2×	733 1.0×	345 1.0×	83 0.3×	402 1.5×	43	2.6k
Kailang Wu China	28	1.4k 1.0×	936 1.3×	621 1.8×	119 0.4×	473 1.8×	50	2.9k
Jose M. Jiménez-Guardeño Spain	18	2.0k 1.4×	903 1.3×	451 1.3×	61 0.2×	314 1.2×	28	2.8k

Countries citing papers authored by Marek Widera

Since Specialization

Citations

This map shows the geographic impact of Marek Widera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Widera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Widera more than expected).

Fields of papers citing papers by Marek Widera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Widera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Widera. The network helps show where Marek Widera may publish in the future.

Co-authorship network of co-authors of Marek Widera

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Widera. A scholar is included among the top collaborators of Marek Widera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Widera. Marek Widera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weber, Birte, André El Saman, Christiane Pallas, et al.. (2024). Extracellular vesicles epitopes as potential biomarker candidates in patients with traumatic spinal cord injury. Frontiers in Immunology. 15. 1478786–1478786. 4 indexed citations

Jacobsen, Henning, Markus Hoffmann, Amy Kempf, et al.. (2023). TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection. Viruses. 15(2). 271–271. 38 indexed citations

Corleis, Björn, Donata Hoffmann, Susanne Rauch, et al.. (2023). Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models. Nature Communications. 14(1). 816–816. 15 indexed citations

Bormann, Maren, Mira Alt, Laura Thümmler, et al.. (2023). Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5. Frontiers in Immunology. 14. 1150667–1150667. 10 indexed citations

Shalamova, Lyudmila, Jochen Wilhelm, Andreas R. Schaubmar, et al.. (2022). Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response. PNAS Nexus. 1(2). pgac067–pgac067. 14 indexed citations

Grikscheit, Katharina, Holger F. Rabenau, Marek Widera, et al.. (2022). Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination. Vaccines. 10(7). 1163–1163. 4 indexed citations

Kohmer, Niko, Barbara Schenk, Katharina Grikscheit, et al.. (2022). Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study. International Journal of Infectious Diseases. 128. 166–175. 5 indexed citations

Wilhelm, Alexander, Christiane Pallas, Rolf Marschalek, & Marek Widera. (2022). Detection and Quantification of SARS-CoV-2 by Real-Time RT-PCR Assay. Methods in molecular biology. 2452. 75–98. 1 indexed citations

Widera, Marek, Alexander Wilhelm, Sebastian Hoehl, et al.. (2021). Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro. The Journal of Infectious Diseases. 224(7). 1109–1114. 43 indexed citations

10.

Collaud, Stéphane, Till Ploenes, Carina Elsner, et al.. (2021). Torque Teno Virus load in lung cancer patients correlates with age but not with tumor stage. PLoS ONE. 16(6). e0252304–e0252304. 9 indexed citations

11.

Widera, Marek, Alexander Wilhelm, Tuna Toptan, et al.. (2021). Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication. Frontiers in Microbiology. 12. 701198–701198. 25 indexed citations

12.

Bojková, Denisa, Kevin Klann, Benjamin Koch, et al.. (2020). Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 583(7816). 469–472. 642 indexed citations breakdown →

13.

Eis‐Hübinger, Anna Maria, Mario Hönemann, Jürgen J. Wenzel, et al.. (2020). Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples. Journal of Clinical Virology. 127. 104381–104381. 34 indexed citations

14.

Westhaus, Sandra, Frank‐Andreas Weber, Sabrina Schiwy, et al.. (2020). Detection of SARS-CoV-2 in raw and treated wastewater in Germany – Suitability for COVID-19 surveillance and potential transmission risks. The Science of The Total Environment. 751. 141750–141750. 265 indexed citations

15.

Francois, Sandra, et al.. (2020). HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells. PLoS ONE. 15(1). e0218905–e0218905. 3 indexed citations

16.

Ruzsics, Zsolt, Adalbert Krawczyk, Marek Widera, et al.. (2020). A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication. Frontiers in Microbiology. 11. 601555–601555. 10 indexed citations

17.

Korth, Johannes, Olympia E. Anastasiou, Jan Hinrich Bräsen, et al.. (2019). The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation. Journal of Clinical Virology. 113. 14–19. 8 indexed citations

18.

Korth, Johannes, Olympia E. Anastasiou, Jens Verheyen, et al.. (2018). Impact of immune suppressive agents on the BK-Polyomavirus non coding control region. Antiviral Research. 159. 68–76. 10 indexed citations

19.

Lavender, Kerry J., Craig S. Pace, Kathrin Sutter, et al.. (2017). An advanced BLT-humanized mouse model for extended HIV-1 cure studies. AIDS. 32(1). 1–10. 54 indexed citations

20.

Pfeiffer, Tanya, Steffen Erkelenz, Marek Widera, Heiner Schaal, & Valerie Bosch. (2013). Mutational analysis of the internal membrane proximal domain of the HIV glycoprotein C-terminus. Virology. 440(1). 31–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact